KMTSKestra Medical Technologies, Ltd.

$26.95+8.0% 1Y

Is the price fair?

What KMTS's price assumes

Kestra Medical Technologies, Ltd. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 12.3× revenue.

12.3

Price / sales · no P/E: the last twelve months did not end in a profit

Price / book
5.93

Price / book · today's price, trailing year to Jul 31, 2026

EV / sales
11.2

EV / sales

Details›
Price / booktoday's price, trailing year to Jul 31, 2026
5.93
EV / EBIToperating margin −134%: the multiple describes the denominator
not meaningful
EV / salestoday's price, trailing year to Jul 31, 2026
11.2
Market capitalisation
$1.32B

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.